These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 11604985

  • 1. Treatment with BAT monoclonal antibody decreases tumor burden in a murine model of leukemia/lymphoma.
    Hardy B, Indjiia L, Rodionov G, Raiter A, Inbal A.
    Int J Oncol; 2001 Nov; 19(5):897-902. PubMed ID: 11604985
    [Abstract] [Full Text] [Related]

  • 2. Immune stimulatory and anti-tumor properties of anti-CD3 and BAT monoclonal antibodies: a comparative study.
    Hardy B, Kovjazin R, Raiter A, Ganor N, Novogrodsky A.
    Hum Antibodies; 1997 Nov; 8(2):95-8. PubMed ID: 9289394
    [Abstract] [Full Text] [Related]

  • 3. A monoclonal antibody against a human B lymphoblastoid cell line induces tumor regression in mice.
    Hardy B, Yampolski I, Kovjazin R, Galli M, Novogrodsky A.
    Cancer Res; 1994 Nov 15; 54(22):5793-6. PubMed ID: 7954401
    [Abstract] [Full Text] [Related]

  • 4. CD4+ T lymphocytes as a primary cellular target for BAT mAb stimulation.
    Raiter A, Rodionov G, Novogrodsky A, Hardy B.
    Int Immunol; 2000 Nov 15; 12(11):1623-8. PubMed ID: 11058582
    [Abstract] [Full Text] [Related]

  • 5. Apoptosis-related gene and protein expression in human lymphoma xenografts (Raji) after low dose rate radiation using 67Cu-2IT-BAT-Lym-1 radioimmunotherapy.
    Kroger LA, DeNardo GL, Gumerlock PH, Xiong CY, Winthrop MD, Shi XB, Mack PC, Leshchinsky T, DeNardo SJ.
    Cancer Biother Radiopharm; 2001 Jun 15; 16(3):213-25. PubMed ID: 11471486
    [Abstract] [Full Text] [Related]

  • 6. BAT mAb induces lymphopoiesis in nude mice.
    Hardy B, Niv Y, Fadaeev L, Raiter A.
    Int Immunol; 2005 May 15; 17(5):615-9. PubMed ID: 15802304
    [Abstract] [Full Text] [Related]

  • 7. Tumor dormancy and cell signaling. II. Antibody as an agonist in inducing dormancy of a B cell lymphoma in SCID mice.
    Racila E, Scheuermann RH, Picker LJ, Yefenof E, Tucker T, Chang W, Marches R, Street NE, Vitetta ES, Uhr JW.
    J Exp Med; 1995 Apr 01; 181(4):1539-50. PubMed ID: 7535341
    [Abstract] [Full Text] [Related]

  • 8. Tumor-cell vaccination induces tumor dormancy in a murine model of B-cell leukemia/lymphoma (BCL1).
    Morecki S, Pugatsch T, Levi S, Moshel Y, Slavin S.
    Int J Cancer; 1996 Jan 17; 65(2):204-8. PubMed ID: 8567118
    [Abstract] [Full Text] [Related]

  • 9. Prevention of melanoma metastases in lungs of BAT treated and peptide immunized mice.
    Feinmesser M, Raiter A, Hardy B.
    Int J Oncol; 2006 Oct 17; 29(4):911-7. PubMed ID: 16964387
    [Abstract] [Full Text] [Related]

  • 10. [Therapeutic effect of agonistic CD40 monoclonal antibody combined with CTL on hu-SCID mouse B lymphoma model].
    Zhou H, Xi H, Ma QR, Chen C, Zhang F, Zhang XG, Gu ZJ.
    Zhonghua Zhong Liu Za Zhi; 2007 Mar 17; 29(3):181-5. PubMed ID: 17649632
    [Abstract] [Full Text] [Related]

  • 11. In vivo studies using bispecific antibodies (anti-CD3 x anti-idiotype) and CD28-induced costimulation in the BCL1 lymphoma.
    Demanet C, Brissinck J, De Jonge J, Thielemans K.
    J Hematother; 1995 Oct 17; 4(5):363-8. PubMed ID: 8581370
    [Abstract] [Full Text] [Related]

  • 12. Therapy with unlabeled and 131I-labeled pan-B-cell monoclonal antibodies in nude mice bearing Raji Burkitt's lymphoma xenografts.
    Buchsbaum DJ, Wahl RL, Normolle DP, Kaminski MS.
    Cancer Res; 1992 Dec 01; 52(23):6476-81. PubMed ID: 1423295
    [Abstract] [Full Text] [Related]

  • 13. Monoclonal antibody against a Burkitt lymphoma-associated antigen.
    Wiels J, Fellous M, Tursz T.
    Proc Natl Acad Sci U S A; 1981 Oct 01; 78(10):6485-8. PubMed ID: 7031655
    [Abstract] [Full Text] [Related]

  • 14. Anti-B4-blocked ricin immunotoxin shows therapeutic efficacy in four different SCID mouse tumor models.
    Shah SA, Halloran PM, Ferris CA, Levine BA, Bourret LA, Goldmacher VS, Blättler WA.
    Cancer Res; 1993 Mar 15; 53(6):1360-7. PubMed ID: 7680284
    [Abstract] [Full Text] [Related]

  • 15. H-40, an antigen controlled by an Igh-linked gene and recognized by cytotoxic T lymphocytes. II. Recognition of H-40 as a tumor antigen in leukemic animals.
    Henderson LA, Ciavarra R, Riblet R, Forman J.
    J Immunol; 1984 Nov 15; 133(5):2778-85. PubMed ID: 6434638
    [Abstract] [Full Text] [Related]

  • 16. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
    Phillips KE, Herring B, Wilson LA, Rickford MS, Zhang M, Goldman CK, Tso JY, Waldmann TA.
    Cancer Res; 2000 Dec 15; 60(24):6977-84. PubMed ID: 11156399
    [Abstract] [Full Text] [Related]

  • 17. Establishment of new SCID and nude mouse models of human B leukemia/lymphoma and effective therapy of the tumors with immunotoxin and monoclonal antibody: marked difference between the SCID and nude mouse models in the antitumor efficacy of monoclonal antibody.
    Kawata A, Yoshida M, Okazaki M, Yokota S, Barcos M, Seon BK.
    Cancer Res; 1994 May 15; 54(10):2688-94. PubMed ID: 8168098
    [Abstract] [Full Text] [Related]

  • 18. Allogeneic cell therapy in murine B-cell leukemia (BCL1): 2. The role of non-activated and rIL-2-activated CD4+ and CD8+ T cells in immunotherapy for leukemia.
    Weiss L, Reich S, Slavin S.
    Cytokines Cell Mol Ther; 1999 Sep 15; 5(3):153-8. PubMed ID: 10641573
    [Abstract] [Full Text] [Related]

  • 19. Immunotherapy of murine leukemias by monoclonal antibody. I. Effect of passively administered antibody on growth of transplanted tumor cells.
    Kirch ME, Hammerling U.
    J Immunol; 1981 Aug 15; 127(2):805-10. PubMed ID: 6788849
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.